Moderna on Wednesday announced it was scaling down manufacturing of its COVID vaccine, an updated version of which was approved this week by U.S. regulators, to align with lower post-pandemic demand and help the Cambridge, Mass.-based company sooner hit its target of 75% to 80% gross margin growth. But it also hints at the difficulty … Continue reading Moderna to Reduce COVID Vaccine Output as Pandemic Wanes